Pfizer: MDL For Cases Alleging Depo-Provera Caused Tumors Belongs In New York
WASHINGTON, D.C. — The manufacturer of Depo-Provera XE "Depo-Provera" , a long-lasting injectable contraceptive, agreed that cases alleging that the product caused women to develop intracranial meningiomas, a type of brain...To view the full article, register now.
Already a subscriber? Click here to view full article